Form 8-K - Current report:
SEC Accession No. 0001493152-23-017946
Filing Date
2023-05-17
Accepted
2023-05-17 16:30:17
Documents
12
Period of Report
2023-05-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52765
  Complete submission text file 0001493152-23-017946.txt   227512

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abeo-20230517.xsd EX-101.SCH 3257
3 XBRL LABEL FILE abeo-20230517_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE abeo-20230517_pre.xml EX-101.PRE 22379
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3599
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 23932161
SIC: 2834 Pharmaceutical Preparations